Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia

Schizophrenia Research

Volumn 106, Issue 2-3, 2008, Pages 140-147

  Ballmaier, Martina ^a,b,c   Schlagenhauf, Florian ^a   Toga, Arthur W ^b   Gallinat, Jürgen ^a   Koslowski, Michael ^a   Zoli, Michele ^d   Hojatkashani, Cornelius ^b   Narr, Katherine L ^b   Heinz, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Affective flattening; Basal ganglia; Non medicated schizophrenia; Putamen; Surface mapping

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BLUNTED AFFECT; BRAIN MAPPING; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; FEMALE; HUMAN; IMAGE PROCESSING; MALE; NEGATIVE SYNDROME; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; SCHIZOPHRENIA; SEX RATIO; STRIATE CORTEX; UNMEDICATED SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA; BRAIN MAPPING; CORPUS STRIATUM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NUCLEUS ACCUMBENS; SCHIZOPHRENIA;

EID: 56049087741     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.08.025     Document Type: Article

References (44)

1. Anderson M.J., and Legendre P. An empirical comparison of permutation methods for tests of partial regression coefficients in a linear model. J. Statist. Comput. and Simul. 62 (1999) 271-303
2. Anderson M.J., and Ter Braak C.J.F. Permutation tests for multi-factorial analysis of variance. J. Statist. Comput. and Simul. 73 (2003) 85-113
3. Apostolova L.G., Dutton R.A., Dinov I.D., Hayashi K.M., Toga A.W., Cummings J.L., and Thompson P.M. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch. Neurol. 63 (2006) 693-699
4. Ballmaier M., Toga A.W., Siddarth P., Blanton R.E., Levitt J.G., Lee M., and Caplan R. Thought disorder and nucleus accumbens in childhood: a structural MRI study. Psychiatry Res. 130 (2004) 43-55
5. Ballmaier M., Narr K.L., Toga A.W., Elderkin-Thompson V., Thompson P.M., Hamilton L., Haroon E., Pham D., Heinz A., and Kumar A. Hippocampal morphology and distinguishing late-onset from early-onset elderly depression. Am. J. Psychiatry 165 (2008) 229-237
6. 18F]Fluoro-L-dopa positron emission tomography study with voxel-based analysis. Psychiatry Res. 154 (2007) 115-124
7. Breier A., Buchanan R.W., Elkashef A., Munson R.C., Kirkpatrick B., and Gellad F. Brain morphology in schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch. Gen. Psychiatry 49 (1992) 921-926
8. Chua S.E., Cheung C., Cheung V., Tsang J.T.K., Chen E.Y.H., Wong J.C.H., Cheung J.P.Y., Yip L., Tai K., Suckling J., and McAlonan G.M. Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr. Res. 89 (2007) 12-21
9. Corson P.W., Nopoulos P., Andreasen N.C., Heckel D., and Arndt S. Caudate size in first-episode neuroleptic-naïve schizophrenic patients measured using an artificial neural network. Biol. Psychiatry 46 (1999) 712-720
10. Crespo-Facorro B., Paradiso S., Andreasen N.C., O'Leary D.S., Watkins G.L., Ponto L.L., and Hichwa R.D. Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and unpleasant odors. JAMA 286 (2001) 427-435
11. Dazzan P., Morgan K.D., Orr K.G., Hutchinson G., Chitnis X., Suckling J., Fearon P., Salvo J., McGuire P.K., Mallett R.M., Jones P.B., Leff J., and Murray R.M. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 127 (2004) 143-153
12. Dunn R.T., Kimbrell T.A., Ketter T.A., Frye M.A., Willis M.W., Luckenbaugh D.A., and Post R.M. Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol. Psychiatry 51 (2002) 387-399
13. First M.B., Spitzer R.L., Gibbo M., and Williams J. Structural Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition with Psychotic Screen, SCID-I/P W/PSY SCREEN (2001), New York State Psychiatric Institute, Biometrics Research, New York
14. Glenthoj A., Glenthoj B.Y., Mackeprang T., Pagsberg A.K., Hemmingsen R.P., Hernigan T.L., and Baaré W.F.C. Basal ganglia volumes in drug-naïve first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res. 154 (2007) 199-208
15. Grace A.A. Gating of the information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res. Rev. 31 (2000) 330-341
16. Guillin O., Abi-Dargham A., and Laruelle M. Neurobiology of dopamine in schizophrenia. Int. Rev. Neurobiol. 78 (2007) 1-39
17. Gunduz H., Wu H., Ashtari M., Bogerts B., Crandall D., Robinson D.G., Alvir J., Lieberman J., Kane J., and Bilder W. Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol. Psychiatry 51 (2002) 801-818
18. Hasler G., Fromm S., Alvarez R.P., Luckenbaugh D.A., Drevets W.C., and Grillon C. Cerebral blood flow in immediate and sustained anxiety. J. Neurosci. 27 (2007) 6313-6319
19. Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia: psychopathological and behavioral correlates. Eur. Psychiatry 17 (2002) 9-16
20. Heinz A., Knable M.B., Coppola R., Gorey J.G., Jones D.W., Lee K.S., and Weinberger D.W. Psychomotor slowing, negative symptoms and dopamine receptor availability: an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients. Schizophr. Res. 31 (1998) 19-26
21. Holcomb H.H., Cascella N.G., Thaker G.K., Medoff D.R., Dannals R.F., and Tamminga C.A. Functional sites of PET/FDG studies with and without haloperidol. Am. J. Psychiatry 153 (1996) 41-49
22. Hwang J., Lyoo I.K., Dager S.R., Friedman S.D., Oh J.S., Lee J.Y., Kim S.J., Dunner D.L., and Renshaw P.F. Basal ganglia shape alterations in bipolar disorder. Am. J. Psychiatry 163 (2006) 276-285
23. Juckel G., Schlagenhauf F., Koslowski M., Wüstenberg T., Villringer A., Knutson B., Wrase J., and Heinz A. Dysfunction of ventral striatal reward prediction in schizophrenia. NeuroImage 29 (2006) 409-416
24. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale, PANNS for schizophrenia. Schizophr. Bull. 13 (1987) 261-276
25. Keshavan M.S., Rosenberg D., Sweeney J.A., and Pettegrew J.W. Decreased caudate volume in neuroleptic-naïve psychotic patients. Am. J. Psychiatry 155 (1998) 774-778
26. Lehéricy S., Ducros M., Van De Moortele P.F., Francois C., Thivard L., Poupon C., Swindale N., Ugurbil K., and Kim S.A. Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans. Ann. Neurol. 55 (2004) 522-529
27. Levy R., Friedman H.R., Davachi L., and Goldman-Rakic P.S. Differential activation of the caudate nucleus in primates performing spatial and nonspatial working memory tasks. J. Neuroscience 17 (1997) 3870-3882
28. Mamah D., Wang L., Barch D., de Erausquin G.A., Gado M., and Csernansky J.G. Structural analysis of the basal ganglia in schizophrenia. Schizophrenia Res. 89 (2007) 59-71
29. Manoach D.S., Gollub R.L., Benson E.S., Searly M.M., Goff D.C., Halpern E., Saper C.B., and Rauch S.L. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol. Psychiatry 48, (2000) 99-109
30. Menon M.F., Anagnoson R.T., Glover G.H., and Pfefferbaum A. Functional magnetic resonance imaging evidence for disrupted basal ganglia function in schizophrenia. Am. J. Psychiatry 158 (2001) 646-649
31. Morey R.A., Inan S., Mitchell T.V., Perkins D.O., Lieberman J.A., and Belge A. Imaging frontostriatal functions in ultra-high-risk, early- and chronic schizophrenia during executive processing. Arch. Gen. Psychiatry 62 (2005) 254-262
32. Narr K.L., Thompson P.M., Szeszko P., Robinson D., Jang S., Woods R.P., Kim S., Hayashi K.M., Asunction D., Toga A.W., and Bilder R.M. Regional specificity of hippocampal volume reductions in first-episode schizophrenia. Neuroimage 21 (2004) 1563-1575
33. Pially J., d'Amato T., Saoud M., and Royet J.P. Left temporo-limbic and orbital dysfunction in schizophrenia during odor familiarity and hedonicity judgments. Neuroimage 29 (2006) 302-313
34. Prince J.A., Harro J., Blennow K., Gottfries C.G., and Oreland L. Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics. Neuropsychopharmacology 22 (2000) 284-292
35. Scherk H., and Falkai P. Effects of antipsychotics on brain structure. Curr. Opin. Psychiatry 19 (2006) 145-150
36. Sewards T.V., and Sewards M.A. Representations of motivational drives in mesial cortex, medial thalamus, hypothalamus and midbrain. Brain Res. Bull. 61 (2003) 25-49
37. Shihabuddin L., Buchsbaum M.S., Hazlett E.A., Mehmet Haznedar M., Harvey P.D., Newmann A., Schnur D.B., Spiegel-Cohen J., Wei T., Machac J., Knesaurek K., Vallabhajosula S., Biren M.A., Ciaravolo T.M., and Luu-Hsia C. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch. Gen. Psychiatry 55 (1998) 235-243
38. Shihabuddin L., Buchsbaum M.S., Hazlett E.A., Silverman J., New A., Brickman A.M., Mitropoulou V., Nunn M., Fleischman M.B., Tang C., and Siever L.J. Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch. Gen. Psychiatry 58 (2001) 877-884
39. Sinha R., Lacadie C., Skudlarski P., and Wexler B.E. Neural circuits underlying emotional distress in humans. Ann. N. Y. Acad. Sci. 1032 (2004) 254-257
40. Sled J.G., and Pike G.B. Standing-wave and RF penetration artifacts caused by elliptic geometry: an electrodynamic analysis of MRI. IEEE Trans. Med. Imaging. 17 (1998) 653-662
41. Takahashi H., Koeda M., Oda K., Matsuda T., Matsushima E., Matsurra M., Asai K., and Okubo Y. An fMRI study of differential neural response to affective pictures in schizophrenia. Neuroimage 22 (2005) 1247-1254
42. Taylor S., Christensen J.D., Holcomb J.M., and Garver D.L. Volume increases in striatum associated with positive symptom reduction in schizophrenia: a preliminary observation. Psychiatry Res. 140 (2005) 85-89
43. Thompson P.M., Hayashi K.M., de Zubicaray G., Janke A.L., Rose S.E., Semple J., Herman D., Hong M.S., Dittmer S.S., Doddrell D.M., and Toga A.W. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 23 (2003) 994-1005
44. Woods R.P., Grafton S.T., Watson J.D., Sicotte N.L., and Mazziotta J.C. Automated image registration: II. Intersubject validation of linear and nonlinear models. J. Comput. Assist. Tomogr. 22 (1998) 153-165